We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Savolitinib Global Phase II Trial Initiated in EGFR

News   Jun 25, 2016

 
Savolitinib Global Phase II Trial Initiated in EGFR
 
 
 

RELATED ARTICLES

Protein Gives Identical Cells Individuality

News

New insight into a protein's role in regulating tight DNA packing could have implications for combating tumor cell resistance to anti-cancer treatments.

READ MORE

Cellular Pathway Tied to Cancer

News

Scientists have discovered a cellular pathway tied to cancer that may be helpful for reducing side effects and extending duration of immunotherapy in some patients with hepatocellular carcinoma, the most common form of liver cancer.

READ MORE

Uncovering Chemo-resistance in Cancer

News

Some cancers do not respond to treatment with one of the most effective chemotherapy drugs: 5-Fluorouracil (5-FU) – now we know why.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE